CA26506-2 - 0x0000000000003A3A

Study Number: CA26506
Group Number: 2
Study Requirement: Healthy Normal Female
Stipend: $5,110.00

Study Criteria:

  • Age: 18 - 55
  • BMI: 18 - 32
  • Weight Restriction: minimum weight 111 lbs

Study Information:

  • Indication: This investigational medication is being developed to treat cancer.
  • Route of Administration: Oral
  • Blood Draws: 51

Study Schedule:

  • Schedule Type: Long Term
  • Study Length: Two - 9 Night Stays & 1 Phone Call

Screening Dates:

Event Day Event Date Site
Tuesday 11/13/2018 Phoenix
Friday 11/16/2018 Phoenix

Doctor Exam Dates:

Event Day Event Date Site
Wednesday 11/21/2018 Phoenix
Monday 11/26/2018 Phoenix

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Friday 11/30/2018 11:00:00 AM Sunday 12/9/2018 9:00:00 AM 1 Phoenix
Check-In Friday 12/14/2018 11:00:00 AM Sunday 12/23/2018 9:00:00 AM 2 Phoenix
Phone participant* Saturday 12/29/2018 11:30:00 AM 2 Phoenix